logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Lung Cancer cover

Lung Cancer

IF4.4
Papers1001
Citations14311
Journal Papers 906
Publication Date
delete
Multicenter case series of pulmonary sclerosing pneumocytoma coinciding with typical carcinoid: Shared AKT1 p.E17K mutation in mixed-growth lesions
deleteLung Cancer
IF4.4
delete2026-10-04
delete0
PREAI
deleteWeijie Chen; Yongtong Wang; Yue Wang; Runan Zhao; Zhengwei Dong; Yan Huang; Likun Hou; Chunyan Wu; Liye Zhang; Huikang Xie
deleteShare
deleteSave
Lung cytology in the diagnostic workflow: A real-world study of its clinical impact
deleteLung Cancer
IF4.4
delete2026-10-03
delete0
PREAI
deleteElisabetta Maffei; Chiara Ciaparrone; Angela D’Ardia; Sara Gaeta; Francesco Sabbatino; Antonio Galderisi; Pio Zeppa; Luka Brcic; Alessandro Caputo
deleteShare
deleteSave
Trial-Specific absolute Disease-Free survival effects of postoperative PD-1/PD-L1 blockade after complete resection of NSCLC: A systematic Review: Absolute DFS with adjuvant PD-1/PD-L1 blockade
deleteLung Cancer
IF4.4
delete2026-10-03
delete0
PREAI
deleteZhiheng Yao; Xinyuan Wang; Hanliang Zhang; Yizhou Huang; Zhenyuan Yang; Chun Chen; Bin Zheng; Hongmu Li
deleteShare
deleteSave
Second-line therapy in extensive-stage small cell lung cancer: an unmet need highlighted by real-world evidence from the LALUCA registry
deleteLung Cancer
IF4.4
delete2026-09-30
delete0
deleteOAAI
deleteDaniel Moser; Anna Lang-Stöberl; Hannah Fabikan; Julie Krainer-Jacobs; Oliver Illini; Leyla Ay; Nino Müser; Christoph Weinlinger; Vania Mikaela Rodriguez; Georg-Christian Funk; Marie-Kathrin Breyer; Robab Breyer-Kohansal; Arschang Valipour; Maximilian J. Hochmair
deleteShare
deleteSave
Exploratory analysis of extracellular vesicle Profile changes during pembrolizumab treatment in NSCLC
deleteLung Cancer
IF4.4
delete2026-09-29
delete0
PREAI
deleteYuta Hirano; Shigehiro Yagishita; Yuki Shinno; Yasushi Goto; Jun Araya; Yusuke Yamamoto; Yu Fujita
deleteShare
deleteSave
Systemic and intracranial activity of antibody–drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis
deleteLung Cancer
IF4.4
delete2026-09-28
delete0
PREAI
deleteSusu Zhou; Jiayi Tan; Vishw Patel; Noriko Kishi; Komal Akhtar; Sam Benjamin; Jade Homsi; Che-Kai Tsao
deleteShare
deleteSave
Atezolizumab plus chemotherapy for Asian vs. non-Asian patients with extensive-stage small-cell lung cancer: A propensity score matched pooled analysis of four phase 3 trials
deleteLung Cancer
IF4.4
delete2026-09-27
delete0
deleteOAAI
deleteShuang Zhang; Martin Reck; Charles Rudin; Shun Lu; Makoto Nishio; Baohui Han; Nobuyuki Yamamoto; Ying Liu; Yanjun Shi; Dandan Hu; Stephen V Liu
deleteShare
deleteSave
Real-world progression-free survival with erlotinib versus osimertinib in EGFR L858R + T790M compound mutation non-small cell lung Cancer: An exploratory analysis of the MSK-CHORD dataset
deleteLung Cancer
IF4.4
delete2026-09-27
delete0
PREAI
deleteZeinab Dalloul; Ahmad Abboud; Iman Dalloul; Mahmoud Abdelsalam
deleteShare
deleteSave
Concomitant medications and outcomes of bispecific T-cell engager therapy: A propensity-matched study of tarlatamab in ES-SCLC
deleteLung Cancer
IF4.4
delete2026-09-26
delete0
PREAI
deleteMostafa Eysha; Alexis Green; Mohamed M. Khamis; Momo Arai; Brock McKenzie; Mariah Black; Islam Hamza Zaki; Bingnan Zhang; Jeffrey M. Clarke; Nicholas DeVito; Laura Alder
deleteShare
deleteSave
More than a risk factor: alcohol use following diagnosis in non-small cell lung cancer patients
deleteLung Cancer
IF4.4
delete2026-09-24
delete0
deleteOAAI
deleteSara E. Ellis; Peter G. Shields; John V. Myers; Sarah A. Reisinger; Alan K. Davis; Barbara L. Andersen
deleteShare
deleteSave
Pathological complete necrosis after pulmonary thermal ablation: a systematic review and meta-analysis of ablate-and-resect studies
deleteLung Cancer
IF4.4
delete2026-09-21
delete0
PREAI
deleteKaixin Zhao; Qiuxi Zhou; Xinming Nie; Yong Chen; Chenghao Wang; Qiang Zhou; Yongtao Han; Wenwu He
deleteShare
deleteSave
Time-dependent impact of programmed death-ligand 1 expression on early progression and long-term response to first-line osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer
deleteLung Cancer
IF4.4
delete2026-09-21
delete0
deleteOAAI
deleteToshiyuki Sumi; Yutaro Nagano; Osamu Honjo; Tatsuru Ishikawa; Sayaka Kudo; Shun Kondoh; Masami Yamazoe; Keiki Yokoo; Yuta Koshino; Makoto Shioya; Yuta Sudo; Kanami Nagano; Hayato Yabe; Yuichiro Asai; Hirotaka Nishikiori; Mamoru Takahashi; Hirofumi Chiba
deleteShare
deleteSave
Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial
deleteLung Cancer
IF4.4
delete2026-09-21
delete0
deleteOAAI
deleteRoberta Eufrasia Ledda; Federica Sabia; Kyongmin Sarah Beck; Gianluca Milanese; Margherita Ruggirello; Maurizio Balbi; Luigi Rolli; Mattia Boeri; Gabriella Sozzi; Nicola Sverzellati; Alfonso Vittorio Marchianò; Ugo Pastorino
deleteShare
deleteSave
Robotic-assisted bronchoscopic biopsy and EBUS-TBNA in lung cancer: An outcome comparison between clinical and pathological staging
deleteLung Cancer
IF4.4
delete2026-09-21
delete0
PREAI
deleteSebastian Fernandez-Bussy; Regina M. Murillo-Torres; Tatiana A. Rojas-Zapata; Alejandra Yu Lee-Mateus; Paola Gutierrez-Gallegos; David Abia-Trujillo; Linh H. Vu; Ryan M. Chadha; Kelly S. Robertson; Bryan C. Husta
deleteShare
deleteSave
Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors
deleteLung Cancer
IF4.4
delete2026-09-17
delete0
PREAI
deleteAyaka Yamada; Hakim Ali Salman; Kaoru Tanaka; Yuko Kinoshita; Miku Kawaguchi; Yuto Takada; Hisatoshi Yamao; Sanae Iwasaki; Takeshi Shimoide; Atsushi-Doksa Lee; Hidetoshi Hayashi; Akifumi Enomoto
deleteShare
deleteSave
Corrigendum to “The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies” [Lung Cancer 204 (2025) 108585]
deleteLung Cancer
IF4.4
delete2026-09-06
delete0
PREAI
deletePrasanth Sekar; Ashmitha Ashok Kumar; Ian Hughes; Robert Mason; Marcin Dzienis
deleteShare
deleteSave
Beyond disease-free survival in adjuvant ALK-targeted therapy: lessons from ELEVATE and ALINA
deleteLung Cancer
IF4.4
delete2026-09-05
delete0
PREAI
deleteLucio Buffoni
deleteShare
deleteSave
Corrigendum to “EML4-ALK fusion in small cell lung cancer: clinical and molecular insights from a rare case” [Lung Cancer 202 (2025) 108497]
deleteLung Cancer
IF4.4
delete2026-09-04
delete0
PREAI
deleteGhina Jaber; Chris Raffoul; Tasnim Diab; Sara Sinno; Zeina Barakat; Hazem I. Assi
deleteShare
deleteSave
Characterization of the genomic and transcriptomic landscape of invasive non-mucinous lung adenocarcinoma based on IASLC grading
deleteLung Cancer
IF4.4
delete2026-09-03
delete0
PREAI
deleteLu He; Xianfeng Xu; Lingfeng Bi; Chen Ji; Zhiwen Li; Yating Fu; Meng Zhu; Cheng Wang; Guangfu Jin; Hongxia Ma; Weimin Li; Zhoufeng Wang; Na Qin; Dong Hang; Hongbing Shen
deleteShare
deleteSave
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes
deleteLung Cancer
IF4.4
delete2026-09-02
delete0
deleteOAAI
deleteRafael Oliveira; Tarje Halvorsen; Kristin Killingberg; Elisabeth Fritzke Emdal; Vibeke Grotnes Dale; Bjørn Henning Grønberg; Pål Sætrom
deleteShare
deleteSave